Business

Wellbeing Digital Announces Resignation of Directors

Wellbeing Digital Announces Resignation of Directors.

articleWellbeing Digital Sciences Inc.November 18, 20224/company/ketamineone-capital-limited/news/wellbeing-digital-announces-resignation-of-directors
Wellbeing Digital Announces Resignation of Directors

About this update from Wellbeing Digital Sciences Inc.

[{"type":"text","content":"\nWellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that James Henning and Steven Inglefield have stepped down as directors of the Company.\n\n“James has served on the Wellbeing board of directors since the Company’s inception,” said Najla Guthrie, CEO of Wellbeing. “Overtime he has made many contributions to the success and growth of the Company, drawing on a wealth of experience gained over a long and successful business career.”\n\n“Steven has served as a Director of the Company as well as its Chief Operating Officer since the purchase of IRP Health Ltd. (“IRP”) and made considerable contributions during his tenure,” said Najla. “With the Company’s decision to divest IRP Health Ltd. (“IRP”), Steven leaves to focus on IRP’s expanding growth.”\n\n“On behalf of the board of directors, the management team and our shareholders, I thank James and Steven for their contributions and wish them the best in their future endeavours,” added Najla.\n\nABOUT WELLBEING DIGITAL SCIENCES\n\nWellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development. For additional information, please visit wellbeingdigital.co.\n\nOn behalf of:\nNajla Guthrie\nChief Executive Officer\nWELLBEING DIGITAL SCIENCES\n\nNotice Regarding Forward-Looking Information:\n\nThis news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to plac...

More updates from Wellbeing Digital Sciences Inc.